An evaluation of PET [positron emission tomography]/CT [computerised tomography] imaging as a predictor of disease free survival following neo-adjuvant chemotherapy for soft tissue sarcoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Doxorubicin; Doxorubicin liposomal; Fludeoxyglucose F-18; Ifosfamide; Mesna; Pegfilgrastim
- Indications Leiomyosarcoma; Liposarcoma; Nerve sheath neoplasms; Soft tissue sarcoma
- Focus Therapeutic Use
- 12 Mar 2021 Biomarkers information updated
- 01 Nov 2012 Planned number of patients changed from 62 to 70 as reporetd by ClinicalTrials.gov.
- 01 Nov 2012 Planned End Date changed from 1 Apr 2012 to 1 Apr 2014 as reporetd by ClinicalTrials.gov.